These results are in agreement with a previous research which reported that isoflavone, one of the main bioactive components of LZD, inhibited IL-6 and IL-8 production through TLR-2-stimulated monocytes in a dose-dependent manner and thus enhanced gut immunity and protected the host from tissue damage in a mouse model of colitis [41]. Here, CXCL8 is linked to colitis.